Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative
European Heart Journal - Cardiovascular Imaging · 2023
DOI: 10.1093/ehjci/jead138 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2023. Verfasst von Claudine Régis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri-Huchard, Paris 75018, France. Hauptthemen laut MEDLINE: Endocarditis, Bacterial, Endocarditis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Aims
In non-operated infective endocarditis (IE), relapse may impair the outcome of the disease. The aim of the study was to evaluate the relationship between end-of-treatment (EOT) fluorodeoxyglucose positron emission tomography/computed tomography FDG-PET/CT results and relapse in non-operated IE either on native or prosthetic valve. Methods and results We included 62 patients who underwent an EOT FDG-PET/CT for non-operated IE performed between 30 and 180 days of antibiotic therapy initiation. Qualitative valve assessment categorized initial and EOT FDG-PET/CT as negative or positive. Quantitative analyses were also conducted. Clinical data from medical charts were collected, including endocarditis team decision for IE diagnosis and relapse. Forty-one (66%) patients were male with a median age of 68 years (57; 80) and 42 (68%) had prosthetic valve IE. End-of-treatment FDG-PET/CT was negative in 29 and positive in 33 patients. The proportion of positive scans decreased significantly compared with initial FDG-PET/CT (53% vs. 77%, respectively, P < 0.0001). All relapses (n = 7, 11%) occurred in patients with a positive EOT FDG-PET/CT with a median delay after EOT FDG-PET/CT of 10 days (0; 45). The relapse rate was significantly lower in negative (0/29) than in positive (7/33) EOT FDG-PET/CT (P = 0.01).
Conclusion
In this series of 62 patients with non-operated IE who underwent EOT FDG-PET/CT, those with a negative scan (almost half of the study population) did not develop IE relapse after a median follow-up of 10 months. These findings need to be confirmed by prospective and larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Department, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri-Huchard, Paris 75018, France.
- Department of Medical Imaging, Institut de cardiologie de Montréal, Université de Montréal, 5000 rue Bélanger, Montréal, Québec H1T 1C8, Canada.
- Infectious Disease Department, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri-Huchard, Paris 75018, France.
- Université Paris Cité, 45 Rue des Saints-Pères, Paris 75006, France.
- Laboratory for Vascular Translational Science, Inserm U1148, 46 rue Henri-Huchard, Paris 75018, France.
- Clinical Investigation Center, Hôpital Bichat-Claude Bernard, AP-HP, 46 rue Henri-Huchard, Paris 75018, France.
ORCID-Profile: Claudine Régis
Zitieren
APA
Régis, C., Thy, M., Mahida, B., Deconinck, L., Tubiana, S., Iung, B., Duval, X., & Rouzet, F. (2023). Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jead138
Vancouver
Régis C, Thy M, Mahida B, Deconinck L, Tubiana S, Iung B, et al. Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative. European Heart Journal - Cardiovascular Imaging. 2023. doi:10.1093/ehjci/jead138
BibTeX
@article{Rgis2023,
author = {Régis, Claudine and Thy, Michael and Mahida, Besma and Deconinck, Laurène and Tubiana, Sarah and Iung, Bernard and Duval, Xavier and Rouzet, François},
title = {Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative},
journal = {European Heart Journal - Cardiovascular Imaging},
year = {2023},
doi = {10.1093/ehjci/jead138}
}
EUVIMED